LAUREN PINGLETON: Open Payments
NPI 1639500051 · STANFORD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 23 payments from 9 companies in 2025. Trend: 2023 $85 · 2024 $102 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $155 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Lilly USA, LLC | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Boston Scientific Corporation | 1 | $14 |
Products named: VRAYLAR, FANAPT, MOUNJARO, AIRSUPRA, CAPLYTA, OTEZLA, Cologuard Collection Kit, Wegovy.
Industry payments across KY — which companies pay providers there.
